Back to search results

Fight Fatigue: Progressive Muscle Relaxation and Walking for ESKD

This study, called "Fight Fatigue," is looking at whether a program combining progressive muscle relaxation and walking can help reduce tiredness in adults with end-stage kidney disease (ESKD) who are on dialysis. You might be able to join if you are 18 or older, have ESKD and have been on hemodialysis for at least 3 months, can read and speak English, feel fatigued, can walk one block, and have a cell phone for text messages. The study is trying to find out if it's possible to recruit enough people, if people stay in the study, and if they find the program acceptable. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 40 participants. It compares a "Fight Fatigue" intervention to an "Attention Control" group receiving education.
What's involved
Participants will receive a 12-week intervention involving education/training followed by text messages. The study measures feasibility and acceptability from baseline to week 12.
Compensation
Not stated in the trial record.
Follow-up
The study measures outcomes until the end of the study at Week 12.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07014111

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Recruiting
NAAges 18+Interventional
University of Illinois at Chicago
~40 participants
Updated 2025-09-26 on ClinicalTrials.gov
What's tested:Fight FatigueAttention Control

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of recruitment
Measured over Baseline to week 12
+3 more outcomes measured

Conditions

End Stage Renal Disease on Dialysis

Explore related trials

Chronic Kidney Disease, Stage 5

Where it's being run

1 sites across 1 states
Illinois1

Who to contact

Mary Hannan, PhD
[email protected]
3123554838
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months
Can read and speak English
Fatigue measured via visual analogue scale, score ≥4 over the last week
Able to stand and walk one block
Has a cell phone that can receive text messages

Exclusion

Patient's nephrologist refuses for them to participate
Unstable angina
Unstable pulmonary disease or pulmonary symptoms that preclude participation
Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-
Cognitive impairment that, in the judgement of the research team, precludes trial participation
Participation in the formative phase of the development of Fight Fatigue

What this trial measures

  • Feasibility of recruitmentBaseline to week 12

    Recruitment metrics (enrolled/invited)

  • Feasibility of retentionBaseline to week 12

    Retention in the study from baseline to week 12

  • AcceptabilityEnd of study (Week 12)

    Participant rating of acceptability (e.g., enjoyable, easy to understand) via Likert scale questions and open ended questions

  • Adherence to the study protocolBaseline to week 12

    Adherence to the intervention measured with adherence to step counts, number/duration of accesses on the study-specific website, and adherence to study procedures as evaluated with number of text messages read/sent messages read.